Batm Advanced Communicat... Share Discussion Threads

[paulisi] 20/8/2021 18:25

Definitely worth a watch.In theory it should follow the UK lead.

[wizzkid211] 20/8/2021 14:26

who said TASE will be interesting on Sunday...

[paulisi] 20/8/2021 11:29

Seems to be a bit of upward movement this morning. Speculation on better than expected results.

[paulisi] 20/8/2021 08:11

A little bit of re-alignment before Monday's results?

[fse] 18/8/2021 18:04

The future of infectious disease 🦠 detection
This article is from early in the year and it gives a decent insight as to the mindset of the company.

[fse] 16/8/2021 16:25

Reminder.....Nat Lab reader

[paulisi] 12/8/2021 09:25

Last year's interimsRevenue 77.4(50m medical)GP 23GM 29.7%OP 2.4Adj OP 2.8Anyone seen any forecasts?I'm expecting significant increase in revenue on medical side and small increase from cyber, until NFV revenues kick in. Once they kick in gross margin will jump.

[doccash] 12/8/2021 08:20

Hi boggy What new product Nothing on news feed?

[boggy] 12/8/2021 07:38

also launch of new product - easily missed with announcing results date also today

[paulisi] 12/8/2021 07:08

Interim results out Mon 23rd

[doccash] 10/8/2021 20:10

Ador has successfully incorporated PCR in the carbon array and has a working prototype of the NATlab system. It is now in the advanced stages of incorporating RCA in the carbon array and is working to complete the development of a full system based on this process, which it expects to be ready for in-hospital trials in H1 2021. Several universities and hospitals, mainly in the UK, Europe, Israel and the USA, are co-operating with Ador on this unique development.


May get some results from these trials soon and this could prove a very lucrative market as need to differentiate quickly other diseases than Covid

[fse] 10/8/2021 16:33

This "edgibility" product for SOHO in co operation with ARM appears to have been missed by the markets.
I cant find anything like it from any other company.
Anyone got any views on this device the size of a cigarette package that would appear essential for the work from home environment.

Here is a link to Telco Systems explaining this new device



Of other interest are comments from several recent articles that suggest the continuation and scale up of testing is benefitting BATM not particularly for Covid tests but the host of other pathogens out there. BATM brokers Shore Capital would or should be aware as to how the company is faring in this respect and they have been quoted.

Heres the comment from Shore.....( I am no fan of Shore but I would be very surprised if they made a misleading statement/analysis). all IMO

"In all this, BATM has produced a whole portfolio of COVID-19 diagnostic tests that ShoreCap views as “validation of its investment strategy in the Bio-Medical division”.

The tech firm is also developing multi-pathogen diagnostics which could be “significant” in the winter months as other respiratory viruses spread.

“We think the portfolio offers multiple attractive diagnostic products in the context of increasing demand for more convenient and rapid tests,” the broker noted."

Added: Regarding the Fool article. It is just a snapshot but it does appear to be taken partly from Shore Capitals own comment. In any event we should be getting an update with figures soon.

[hew] 09/8/2021 11:59

DocCash, I generally agree that the Fool piece does not amount to much; there is little actual analysis, merely a summary of operating areas.

Yes, it gives the strong diagnostic basis alright but for me the NFV field is a major omission - it's a key reason why I'm hanging on. Some implementation already in place but really major opportunities, with relatively low marginal cost of further sales.

What it does rightly mention, but IMO not emphasise sufficiently, is the "strong cyber security division and targets what it describes as “Tier 1” organisations and governments worldwide."

On that I disagree with you that what counts most in those target markets are "more established firms with longer track records". Yes, necessary to be reasonably so but, for such users, I see the top criterion being the most trust-worthy re security, best technology, avoiding (human) penetration, international trust and suchlike. All the stuff that can't be spoken about much, but is absolutely vital. There I see BATM scoring highly.

[doccash] 09/8/2021 07:45

From the fool article I think this is poor analysis

There are also more established tech firms offering cyber security solutions. My concern is BATM could be beaten to new business by these larger, more established firms with longer track records

BATM is hardly a new startup and working closely with ARM etc

[fse] 07/8/2021 15:40

Not a bad analysis by "the fool"
They do not mention NFV products but in all fairness these are only just starting to generate revenue for them and other companies.

[lsoc85] 05/8/2021 19:03

TASE is closed on Fridays and open on Sundays so can't see them releasing until next week... waiting for BATM is like waiting for Godot.

[doccash] 05/8/2021 18:44

Perhaps leak that results out tomorrow?

[wizzkid211] 05/8/2021 16:06

High volume on TASE today 880184 shares traded

[sev22] 04/8/2021 18:29

BATM Advanced Communications has attractive portfolio amid increased demand for COVID-19 testing, says City broker.

[vago] 04/8/2021 17:46

under small caps.

[vago] 04/8/2021 17:40

Just go on to proactive it's one of the days tips.